Eli Lilly's new lipid-lowering drug data released can reduce genetic risk factors for heart disease by 94%

2025-03-31 17:54:13

Eli Lilly and Company announced clinical data on its lipid-lowering drug lepodisiran at the American College of Cardiology meeting, showing that the highest dose of the drug reduced the level of genetic risk factors for heart disease by 94% in a mid-term trial.

Lilly

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Broadcom (AVGO.O) shares rose 5% after the market closed.
                            2025-04-08

                                    EVE Energy responds to US "reciprocal tariff" policy: no cost impact on existing contract deliveries
                            2025-04-08

                                    Nvidia concept sector continues to rise, Zhongdian Port and Hongbo shares hit the daily limit
                            2025-04-10

                                    Apple concept stocks in Hong Kong stocks fell, with Gowin Electronics (01415.HK) down nearly 10%, Sunny Optical Technology (02382.HK) down more than 9%, Q Technology (01478.HK) down 8.5%, AAC Technologies (02018.HK) down 7.7%, Foxconn Technology (02038.HK) and BYD Electronics (00285.HK) down more than 6%.
                            2025-04-09

                                    Foxconn: Sales in March were NT$552.1 billion, up 23% year-on-year.
                            2025-04-05